How The US FDA Honed Remote Tools To Assess Facilities During COVID Inspection Hiatus
Executive Summary
FDA officials outline the impact of using alternative tools to assess manufacturing facilities amid COVID-19 and share key experiences around these, including with remote interactive evaluations.